| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.2 | 8e-05 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0001 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.001 |